MARKET

KLTOW

KLTOW

Klotho Neurosciences, Inc.
NASDAQ
0.1328
-0.0020
-1.47%
Closed 14:29 12/04 EST
OPEN
0.1476
PREV CLOSE
0.1348
HIGH
0.1476
LOW
0.1328
VOLUME
1.88K
TURNOVER
261
52 WEEK HIGH
0.9500
52 WEEK LOW
0.0100
MARKET CAP
--
P/E (TTM)
-0.4069
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at KLTOW last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at KLTOW last week (1117-1121)?
Weekly Report · 11/24 09:51
Weekly Report: what happened at KLTOW last week (1110-1114)?
Weekly Report · 11/17 09:51
Weekly Report: what happened at KLTOW last week (1103-1107)?
Weekly Report · 11/10 09:49
Weekly Report: what happened at KLTOW last week (1027-1031)?
Weekly Report · 11/03 09:49
Weekly Report: what happened at KLTOW last week (1020-1024)?
Weekly Report · 10/27 09:51
Weekly Report: what happened at KLTOW last week (1013-1017)?
Weekly Report · 10/20 09:49
Weekly Report: what happened at KLTOW last week (1006-1010)?
Weekly Report · 10/13 09:51
More
About KLTOW
ANEW Medical, Inc. is a specialty pharmaceutical company. The Company specializes in the development of diagnostics and novel disease-modifying therapies for neurological and age-related disorders. The Company focuses on central nervous systems (CNS) diseases utilizing cell and gene therapies to mitigate age-related pathologies such as Alzheimer's disease (AD), dementia symptoms and neuromuscular diseases. The Company has exclusive worldwide rights to develop and commercialize product platforms based on its proprietary isoform transcribed from the human Klotho gene referred to as secreted Klotho or s-KL. This s-KL protein or gene therapy has been recognized for its potential to mitigate age-related pathologies such as ALS, Alzheimer's and Parkinson's Disease. Its lead gene therapy product candidates are AMI-101 (AAV9-CMV-sKL) for the treatment or prevention of Alzheimer’s disease, and AMI-202 (AAVmyo-Des-sKL) gene therapy product for treatment and prevention of Lou Gehrig’s disease.

Webull offers ANEW Medical Inc stock information, including NASDAQ: KLTOW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KLTOW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KLTOW stock methods without spending real money on the virtual paper trading platform.